Robert W DeSimone

This inventor holds 34 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Kinase Modulators. Top assignees: Neurogen Corporation, Cgi Pharmaceuticals, Inc., Cellular Genomics, Inc.. Active years: 1997-2009.

USPTO Granted Patents = 34 (Patent Applications = 1)

% Patents Active = 73.5

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.4

ph-index = 15

Forward Citations = 636(Granted Patents)

Company Filing History:

Cgi Pharmaceuticals, Inc.

patents

1 out of 1

Cellular Genomics, Inc.

patent

Years Active: 1997-2009

Loading Chart...

Areas of Expertise:

Kinase Activity

GABA Receptor Ligands

Neuropeptide Y1

Imidazo Compounds

Melanin Concentrating Hormone

Bradykinin B2 Receptors

Aminoalkyl Derivatives

Hsp90 Complex

Selective Modulators

Substituted Ureas

Cycloalkyl Compounds

Aryl Derivatives

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7625931 - Certain substituted diphenyl ureas, as modulators of kinase activity (2009-12-01),

2. 7405295 - Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-29),

3. 7393848 - Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-01),

4. 7348326 - [object Object] (2008-03-25),

5. 7312341 - 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof (2007-12-25),

6. 7259164 - Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity (2007-08-21),

7. 7241765 - Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues (2007-07-10),

8. 7189723 - Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity (2007-03-13),

9. 7160885 - Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity (2007-01-09),

10. 7160879 - Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues (2007-01-09),

11. 7015227 - Certain amino-substituted monocycles as kinase modulators (2006-03-21),

12. 6972293 - Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors (2005-12-06),

13. 6919340 - Imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof (2005-07-19),

14. 6906075 - Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues (2005-06-14),

15. 6723730 - Capsaicin receptor ligands (2004-04-20),

Title: The Inventor Robert W DeSimone: Pioneering Innovations in Durham, CT

Introduction: Robert W DeSimone is a distinguished inventor based in Durham, CT, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert W DeSimone holds several recent patents in the areas of renewable energy technologies, medical devices, and advanced materials, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Robert W DeSimone has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of conventional thinking.

Collaborations: Throughout his career, Robert W DeSimone has collaborated with leading research institutions, universities, and industry experts to bring his inventions to life, fostering a culture of innovation and knowledge-sharing.

Conclusion: Robert W DeSimone's passion for innovation, coupled with his relentless drive to make a positive impact on society, solidifies his position as a trailblazing inventor whose work continues to inspire future generations in Durham, CT and beyond.